Literature DB >> 1100308

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.

H B Kostenbauder, R P Rapp, J P McGovren, T S Foster, D G Perrier, H M Blacker, W C Hulon, A W Kinkel.   

Abstract

Comparison of phenytoin plasma concentrations in an intravenous and intramuscular crossover study in 12 healthy ambulant, male subjects indicates that phenytoin administered intramuscularly is absorbed over a period of approximately five days. A model simulating precipitation and redissolution of the drug at the injection site has been shown to satisfactorily fit observed plasma concentration data following intramuscular administration. It is proposed that this model will be useful in the selection of an appropriate dosing regimen in situations in which intramuscular administration of phenytoin is indicated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100308     DOI: 10.1002/cpt1975184449

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

Review 1.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Nonlinear assessment of phenytoin bioavailability.

Authors:  W J Jusko; J R Koup; G Alván
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Authors:  G Lam; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

5.  Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

Authors:  H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; H E Spiegel; J Symington; R Christian; J D Moore; L Weissman; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

6.  Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

7.  Absorption of oral and intramuscular chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers; K Franke; H G Giles
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

8.  A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses.

Authors:  T Tobin; J W Blake
Journal:  Br J Sports Med       Date:  1976-10       Impact factor: 13.800

9.  Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons.

Authors:  J G Lloyd-Jones; P Robinson; R Henson; S R Biggs; T Taylor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

Review 10.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.